Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1228154

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1228154

Global Aesthetic Injectables Market Insights, Forecast to 2029

PUBLISHED:
PAGES: 93 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the Aesthetic Injectables Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Aesthetic Injectables Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Aesthetic Injectables Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Sunken Cheeks or Temples
    • 1.2.3 Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines)
    • 1.2.4 Plumping Up Lips
    • 1.2.5 Enhancing Facial Contour
  • 1.3 Market by Application
    • 1.3.1 Global Aesthetic Injectables Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospital
    • 1.3.3 Beauty Clinic
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Aesthetic Injectables Sales Estimates and Forecasts 2018-2029
  • 2.2 Global Aesthetic Injectables Revenue by Region
    • 2.2.1 Global Aesthetic Injectables Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global Aesthetic Injectables Revenue by Region (2018-2023)
    • 2.2.3 Global Aesthetic Injectables Revenue by Region (2024-2029)
    • 2.2.4 Global Aesthetic Injectables Revenue Market Share by Region (2018-2029)
  • 2.3 Global Aesthetic Injectables Sales Estimates and Forecasts 2018-2029
  • 2.4 Global Aesthetic Injectables Sales by Region
    • 2.4.1 Global Aesthetic Injectables Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global Aesthetic Injectables Sales by Region (2018-2023)
    • 2.4.3 Global Aesthetic Injectables Sales by Region (2024-2029)
    • 2.4.4 Global Aesthetic Injectables Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Aesthetic Injectables Sales by Manufacturers
    • 3.1.1 Global Aesthetic Injectables Sales by Manufacturers (2018-2023)
    • 3.1.2 Global Aesthetic Injectables Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Aesthetic Injectables in 2022
  • 3.2 Global Aesthetic Injectables Revenue by Manufacturers
    • 3.2.1 Global Aesthetic Injectables Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global Aesthetic Injectables Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by Aesthetic Injectables Revenue in 2022
  • 3.3 Global Key Players of Aesthetic Injectables, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global Aesthetic Injectables Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Aesthetic Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Aesthetic Injectables, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Aesthetic Injectables, Product Offered and Application
  • 3.8 Global Key Manufacturers of Aesthetic Injectables, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Aesthetic Injectables Sales by Type
    • 4.1.1 Global Aesthetic Injectables Historical Sales by Type (2018-2023)
    • 4.1.2 Global Aesthetic Injectables Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global Aesthetic Injectables Sales Market Share by Type (2018-2029)
  • 4.2 Global Aesthetic Injectables Revenue by Type
    • 4.2.1 Global Aesthetic Injectables Historical Revenue by Type (2018-2023)
    • 4.2.2 Global Aesthetic Injectables Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global Aesthetic Injectables Revenue Market Share by Type (2018-2029)
  • 4.3 Global Aesthetic Injectables Price by Type
    • 4.3.1 Global Aesthetic Injectables Price by Type (2018-2023)
    • 4.3.2 Global Aesthetic Injectables Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global Aesthetic Injectables Sales by Application
    • 5.1.1 Global Aesthetic Injectables Historical Sales by Application (2018-2023)
    • 5.1.2 Global Aesthetic Injectables Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global Aesthetic Injectables Sales Market Share by Application (2018-2029)
  • 5.2 Global Aesthetic Injectables Revenue by Application
    • 5.2.1 Global Aesthetic Injectables Historical Revenue by Application (2018-2023)
    • 5.2.2 Global Aesthetic Injectables Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global Aesthetic Injectables Revenue Market Share by Application (2018-2029)
  • 5.3 Global Aesthetic Injectables Price by Application
    • 5.3.1 Global Aesthetic Injectables Price by Application (2018-2023)
    • 5.3.2 Global Aesthetic Injectables Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada Aesthetic Injectables Market Size by Type
    • 6.1.1 US & Canada Aesthetic Injectables Sales by Type (2018-2029)
    • 6.1.2 US & Canada Aesthetic Injectables Revenue by Type (2018-2029)
  • 6.2 US & Canada Aesthetic Injectables Market Size by Application
    • 6.2.1 US & Canada Aesthetic Injectables Sales by Application (2018-2029)
    • 6.2.2 US & Canada Aesthetic Injectables Revenue by Application (2018-2029)
  • 6.3 US & Canada Aesthetic Injectables Market Size by Country
    • 6.3.1 US & Canada Aesthetic Injectables Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada Aesthetic Injectables Sales by Country (2018-2029)
    • 6.3.3 US & Canada Aesthetic Injectables Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Aesthetic Injectables Market Size by Type
    • 7.1.1 Europe Aesthetic Injectables Sales by Type (2018-2029)
    • 7.1.2 Europe Aesthetic Injectables Revenue by Type (2018-2029)
  • 7.2 Europe Aesthetic Injectables Market Size by Application
    • 7.2.1 Europe Aesthetic Injectables Sales by Application (2018-2029)
    • 7.2.2 Europe Aesthetic Injectables Revenue by Application (2018-2029)
  • 7.3 Europe Aesthetic Injectables Market Size by Country
    • 7.3.1 Europe Aesthetic Injectables Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe Aesthetic Injectables Sales by Country (2018-2029)
    • 7.3.3 Europe Aesthetic Injectables Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Aesthetic Injectables Market Size
    • 8.1.1 China Aesthetic Injectables Sales (2018-2029)
    • 8.1.2 China Aesthetic Injectables Revenue (2018-2029)
  • 8.2 China Aesthetic Injectables Market Size by Application
    • 8.2.1 China Aesthetic Injectables Sales by Application (2018-2029)
    • 8.2.2 China Aesthetic Injectables Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Aesthetic Injectables Market Size by Type
    • 9.1.1 Asia Aesthetic Injectables Sales by Type (2018-2029)
    • 9.1.2 Asia Aesthetic Injectables Revenue by Type (2018-2029)
  • 9.2 Asia Aesthetic Injectables Market Size by Application
    • 9.2.1 Asia Aesthetic Injectables Sales by Application (2018-2029)
    • 9.2.2 Asia Aesthetic Injectables Revenue by Application (2018-2029)
  • 9.3 Asia Aesthetic Injectables Sales by Region
    • 9.3.1 Asia Aesthetic Injectables Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia Aesthetic Injectables Revenue by Region (2018-2029)
    • 9.3.3 Asia Aesthetic Injectables Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Aesthetic Injectables Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Aesthetic Injectables Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America Aesthetic Injectables Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America Aesthetic Injectables Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Aesthetic Injectables Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America Aesthetic Injectables Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America Aesthetic Injectables Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Aesthetic Injectables Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America Aesthetic Injectables Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America Aesthetic Injectables Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Allergan Plc
    • 11.1.1 Allergan Plc Company Information
    • 11.1.2 Allergan Plc Overview
    • 11.1.3 Allergan Plc Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Allergan Plc Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Allergan Plc Recent Developments
  • 11.2 Galderma SA
    • 11.2.1 Galderma SA Company Information
    • 11.2.2 Galderma SA Overview
    • 11.2.3 Galderma SA Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 Galderma SA Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Galderma SA Recent Developments
  • 11.3 Merz Pharma GmbH & Co KgaA
    • 11.3.1 Merz Pharma GmbH & Co KgaA Company Information
    • 11.3.2 Merz Pharma GmbH & Co KgaA Overview
    • 11.3.3 Merz Pharma GmbH & Co KgaA Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Merz Pharma GmbH & Co KgaA Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Merz Pharma GmbH & Co KgaA Recent Developments
  • 11.4 Sinclair Pharma Plc
    • 11.4.1 Sinclair Pharma Plc Company Information
    • 11.4.2 Sinclair Pharma Plc Overview
    • 11.4.3 Sinclair Pharma Plc Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Sinclair Pharma Plc Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Sinclair Pharma Plc Recent Developments
  • 11.5 Teoxane SA
    • 11.5.1 Teoxane SA Company Information
    • 11.5.2 Teoxane SA Overview
    • 11.5.3 Teoxane SA Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 Teoxane SA Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Teoxane SA Recent Developments
  • 11.6 Bohus BioTech AB
    • 11.6.1 Bohus BioTech AB Company Information
    • 11.6.2 Bohus BioTech AB Overview
    • 11.6.3 Bohus BioTech AB Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 Bohus BioTech AB Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Bohus BioTech AB Recent Developments
  • 11.7 AbbVie Inc
    • 11.7.1 AbbVie Inc Company Information
    • 11.7.2 AbbVie Inc Overview
    • 11.7.3 AbbVie Inc Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 AbbVie Inc Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 AbbVie Inc Recent Developments
  • 11.8 Huadong Medicine Co., Ltd
    • 11.8.1 Huadong Medicine Co., Ltd Company Information
    • 11.8.2 Huadong Medicine Co., Ltd Overview
    • 11.8.3 Huadong Medicine Co., Ltd Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Huadong Medicine Co., Ltd Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Huadong Medicine Co., Ltd Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Aesthetic Injectables Industry Chain Analysis
  • 12.2 Aesthetic Injectables Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Aesthetic Injectables Production Mode & Process
  • 12.4 Aesthetic Injectables Sales and Marketing
    • 12.4.1 Aesthetic Injectables Sales Channels
    • 12.4.2 Aesthetic Injectables Distributors
  • 12.5 Aesthetic Injectables Customers

13 Market Dynamics

  • 13.1 Aesthetic Injectables Industry Trends
  • 13.2 Aesthetic Injectables Market Drivers
  • 13.3 Aesthetic Injectables Market Challenges
  • 13.4 Aesthetic Injectables Market Restraints

14 Key Findings in The Global Aesthetic Injectables Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Aesthetic Injectables Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Aesthetic Injectables Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Sunken Cheeks or Temples
    • 1.2.3 Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines)
    • 1.2.4 Plumping Up Lips
    • 1.2.5 Enhancing Facial Contour
  • 1.3 Market by Application
    • 1.3.1 Global Aesthetic Injectables Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospital
    • 1.3.3 Beauty Clinic
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Aesthetic Injectables Sales Estimates and Forecasts 2018-2029
  • 2.2 Global Aesthetic Injectables Revenue by Region
    • 2.2.1 Global Aesthetic Injectables Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global Aesthetic Injectables Revenue by Region (2018-2023)
    • 2.2.3 Global Aesthetic Injectables Revenue by Region (2024-2029)
    • 2.2.4 Global Aesthetic Injectables Revenue Market Share by Region (2018-2029)
  • 2.3 Global Aesthetic Injectables Sales Estimates and Forecasts 2018-2029
  • 2.4 Global Aesthetic Injectables Sales by Region
    • 2.4.1 Global Aesthetic Injectables Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global Aesthetic Injectables Sales by Region (2018-2023)
    • 2.4.3 Global Aesthetic Injectables Sales by Region (2024-2029)
    • 2.4.4 Global Aesthetic Injectables Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Aesthetic Injectables Sales by Manufacturers
    • 3.1.1 Global Aesthetic Injectables Sales by Manufacturers (2018-2023)
    • 3.1.2 Global Aesthetic Injectables Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Aesthetic Injectables in 2022
  • 3.2 Global Aesthetic Injectables Revenue by Manufacturers
    • 3.2.1 Global Aesthetic Injectables Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global Aesthetic Injectables Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by Aesthetic Injectables Revenue in 2022
  • 3.3 Global Key Players of Aesthetic Injectables, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global Aesthetic Injectables Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Aesthetic Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Aesthetic Injectables, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Aesthetic Injectables, Product Offered and Application
  • 3.8 Global Key Manufacturers of Aesthetic Injectables, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Aesthetic Injectables Sales by Type
    • 4.1.1 Global Aesthetic Injectables Historical Sales by Type (2018-2023)
    • 4.1.2 Global Aesthetic Injectables Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global Aesthetic Injectables Sales Market Share by Type (2018-2029)
  • 4.2 Global Aesthetic Injectables Revenue by Type
    • 4.2.1 Global Aesthetic Injectables Historical Revenue by Type (2018-2023)
    • 4.2.2 Global Aesthetic Injectables Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global Aesthetic Injectables Revenue Market Share by Type (2018-2029)
  • 4.3 Global Aesthetic Injectables Price by Type
    • 4.3.1 Global Aesthetic Injectables Price by Type (2018-2023)
    • 4.3.2 Global Aesthetic Injectables Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global Aesthetic Injectables Sales by Application
    • 5.1.1 Global Aesthetic Injectables Historical Sales by Application (2018-2023)
    • 5.1.2 Global Aesthetic Injectables Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global Aesthetic Injectables Sales Market Share by Application (2018-2029)
  • 5.2 Global Aesthetic Injectables Revenue by Application
    • 5.2.1 Global Aesthetic Injectables Historical Revenue by Application (2018-2023)
    • 5.2.2 Global Aesthetic Injectables Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global Aesthetic Injectables Revenue Market Share by Application (2018-2029)
  • 5.3 Global Aesthetic Injectables Price by Application
    • 5.3.1 Global Aesthetic Injectables Price by Application (2018-2023)
    • 5.3.2 Global Aesthetic Injectables Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada Aesthetic Injectables Market Size by Type
    • 6.1.1 US & Canada Aesthetic Injectables Sales by Type (2018-2029)
    • 6.1.2 US & Canada Aesthetic Injectables Revenue by Type (2018-2029)
  • 6.2 US & Canada Aesthetic Injectables Market Size by Application
    • 6.2.1 US & Canada Aesthetic Injectables Sales by Application (2018-2029)
    • 6.2.2 US & Canada Aesthetic Injectables Revenue by Application (2018-2029)
  • 6.3 US & Canada Aesthetic Injectables Market Size by Country
    • 6.3.1 US & Canada Aesthetic Injectables Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada Aesthetic Injectables Sales by Country (2018-2029)
    • 6.3.3 US & Canada Aesthetic Injectables Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Aesthetic Injectables Market Size by Type
    • 7.1.1 Europe Aesthetic Injectables Sales by Type (2018-2029)
    • 7.1.2 Europe Aesthetic Injectables Revenue by Type (2018-2029)
  • 7.2 Europe Aesthetic Injectables Market Size by Application
    • 7.2.1 Europe Aesthetic Injectables Sales by Application (2018-2029)
    • 7.2.2 Europe Aesthetic Injectables Revenue by Application (2018-2029)
  • 7.3 Europe Aesthetic Injectables Market Size by Country
    • 7.3.1 Europe Aesthetic Injectables Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe Aesthetic Injectables Sales by Country (2018-2029)
    • 7.3.3 Europe Aesthetic Injectables Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Aesthetic Injectables Market Size
    • 8.1.1 China Aesthetic Injectables Sales (2018-2029)
    • 8.1.2 China Aesthetic Injectables Revenue (2018-2029)
  • 8.2 China Aesthetic Injectables Market Size by Application
    • 8.2.1 China Aesthetic Injectables Sales by Application (2018-2029)
    • 8.2.2 China Aesthetic Injectables Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Aesthetic Injectables Market Size by Type
    • 9.1.1 Asia Aesthetic Injectables Sales by Type (2018-2029)
    • 9.1.2 Asia Aesthetic Injectables Revenue by Type (2018-2029)
  • 9.2 Asia Aesthetic Injectables Market Size by Application
    • 9.2.1 Asia Aesthetic Injectables Sales by Application (2018-2029)
    • 9.2.2 Asia Aesthetic Injectables Revenue by Application (2018-2029)
  • 9.3 Asia Aesthetic Injectables Sales by Region
    • 9.3.1 Asia Aesthetic Injectables Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia Aesthetic Injectables Revenue by Region (2018-2029)
    • 9.3.3 Asia Aesthetic Injectables Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Aesthetic Injectables Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Aesthetic Injectables Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America Aesthetic Injectables Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America Aesthetic Injectables Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Aesthetic Injectables Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America Aesthetic Injectables Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America Aesthetic Injectables Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Aesthetic Injectables Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America Aesthetic Injectables Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America Aesthetic Injectables Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Allergan Plc
    • 11.1.1 Allergan Plc Company Information
    • 11.1.2 Allergan Plc Overview
    • 11.1.3 Allergan Plc Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Allergan Plc Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Allergan Plc Recent Developments
  • 11.2 Galderma SA
    • 11.2.1 Galderma SA Company Information
    • 11.2.2 Galderma SA Overview
    • 11.2.3 Galderma SA Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 Galderma SA Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Galderma SA Recent Developments
  • 11.3 Merz Pharma GmbH & Co KgaA
    • 11.3.1 Merz Pharma GmbH & Co KgaA Company Information
    • 11.3.2 Merz Pharma GmbH & Co KgaA Overview
    • 11.3.3 Merz Pharma GmbH & Co KgaA Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Merz Pharma GmbH & Co KgaA Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Merz Pharma GmbH & Co KgaA Recent Developments
  • 11.4 Sinclair Pharma Plc
    • 11.4.1 Sinclair Pharma Plc Company Information
    • 11.4.2 Sinclair Pharma Plc Overview
    • 11.4.3 Sinclair Pharma Plc Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Sinclair Pharma Plc Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Sinclair Pharma Plc Recent Developments
  • 11.5 Teoxane SA
    • 11.5.1 Teoxane SA Company Information
    • 11.5.2 Teoxane SA Overview
    • 11.5.3 Teoxane SA Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 Teoxane SA Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Teoxane SA Recent Developments
  • 11.6 Bohus BioTech AB
    • 11.6.1 Bohus BioTech AB Company Information
    • 11.6.2 Bohus BioTech AB Overview
    • 11.6.3 Bohus BioTech AB Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 Bohus BioTech AB Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Bohus BioTech AB Recent Developments
  • 11.7 AbbVie Inc
    • 11.7.1 AbbVie Inc Company Information
    • 11.7.2 AbbVie Inc Overview
    • 11.7.3 AbbVie Inc Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 AbbVie Inc Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 AbbVie Inc Recent Developments
  • 11.8 Huadong Medicine Co., Ltd
    • 11.8.1 Huadong Medicine Co., Ltd Company Information
    • 11.8.2 Huadong Medicine Co., Ltd Overview
    • 11.8.3 Huadong Medicine Co., Ltd Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Huadong Medicine Co., Ltd Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Huadong Medicine Co., Ltd Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Aesthetic Injectables Industry Chain Analysis
  • 12.2 Aesthetic Injectables Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Aesthetic Injectables Production Mode & Process
  • 12.4 Aesthetic Injectables Sales and Marketing
    • 12.4.1 Aesthetic Injectables Sales Channels
    • 12.4.2 Aesthetic Injectables Distributors
  • 12.5 Aesthetic Injectables Customers

13 Market Dynamics

  • 13.1 Aesthetic Injectables Industry Trends
  • 13.2 Aesthetic Injectables Market Drivers
  • 13.3 Aesthetic Injectables Market Challenges
  • 13.4 Aesthetic Injectables Market Restraints

14 Key Findings in The Global Aesthetic Injectables Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

List of Tables

  • Table 1. Global Aesthetic Injectables Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of Sunken Cheeks or Temples
  • Table 3. Major Manufacturers of Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines)
  • Table 4. Major Manufacturers of Plumping Up Lips
  • Table 5. Major Manufacturers of Enhancing Facial Contour
  • Table 6. Global Aesthetic Injectables Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 7. Global Aesthetic Injectables Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 8. Global Aesthetic Injectables Revenue by Region (2018-2023) & (US$ Million)
  • Table 9. Global Aesthetic Injectables Revenue by Region (2024-2029) & (US$ Million)
  • Table 10. Global Aesthetic Injectables Revenue Market Share by Region (2018-2023)
  • Table 11. Global Aesthetic Injectables Revenue Market Share by Region (2024-2029)
  • Table 12. Global Aesthetic Injectables Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 13. Global Aesthetic Injectables Sales by Region (2018-2023) & (K Units)
  • Table 14. Global Aesthetic Injectables Sales by Region (2024-2029) & (K Units)
  • Table 15. Global Aesthetic Injectables Sales Market Share by Region (2018-2023)
  • Table 16. Global Aesthetic Injectables Sales Market Share by Region (2024-2029)
  • Table 17. Global Aesthetic Injectables Sales by Manufacturers (2018-2023) & (K Units)
  • Table 18. Global Aesthetic Injectables Sales Share by Manufacturers (2018-2023)
  • Table 19. Global Aesthetic Injectables Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 20. Global Aesthetic Injectables Revenue Share by Manufacturers (2018-2023)
  • Table 21. Global Key Players of Aesthetic Injectables, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 22. Aesthetic Injectables Price by Manufacturers 2018-2023 (US$/Unit)
  • Table 23. Global Aesthetic Injectables Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 24. Global Aesthetic Injectables by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aesthetic Injectables as of 2022)
  • Table 25. Global Key Manufacturers of Aesthetic Injectables, Manufacturing Base Distribution and Headquarters
  • Table 26. Global Key Manufacturers of Aesthetic Injectables, Product Offered and Application
  • Table 27. Global Key Manufacturers of Aesthetic Injectables, Date of Enter into This Industry
  • Table 28. Mergers & Acquisitions, Expansion Plans
  • Table 29. Global Aesthetic Injectables Sales by Type (2018-2023) & (K Units)
  • Table 30. Global Aesthetic Injectables Sales by Type (2024-2029) & (K Units)
  • Table 31. Global Aesthetic Injectables Sales Share by Type (2018-2023)
  • Table 32. Global Aesthetic Injectables Sales Share by Type (2024-2029)
  • Table 33. Global Aesthetic Injectables Revenue by Type (2018-2023) & (US$ Million)
  • Table 34. Global Aesthetic Injectables Revenue by Type (2024-2029) & (US$ Million)
  • Table 35. Global Aesthetic Injectables Revenue Share by Type (2018-2023)
  • Table 36. Global Aesthetic Injectables Revenue Share by Type (2024-2029)
  • Table 37. Aesthetic Injectables Price by Type (2018-2023) & (US$/Unit)
  • Table 38. Global Aesthetic Injectables Price Forecast by Type (2024-2029) & (US$/Unit)
  • Table 39. Global Aesthetic Injectables Sales by Application (2018-2023) & (K Units)
  • Table 40. Global Aesthetic Injectables Sales by Application (2024-2029) & (K Units)
  • Table 41. Global Aesthetic Injectables Sales Share by Application (2018-2023)
  • Table 42. Global Aesthetic Injectables Sales Share by Application (2024-2029)
  • Table 43. Global Aesthetic Injectables Revenue by Application (2018-2023) & (US$ Million)
  • Table 44. Global Aesthetic Injectables Revenue by Application (2024-2029) & (US$ Million)
  • Table 45. Global Aesthetic Injectables Revenue Share by Application (2018-2023)
  • Table 46. Global Aesthetic Injectables Revenue Share by Application (2024-2029)
  • Table 47. Aesthetic Injectables Price by Application (2018-2023) & (US$/Unit)
  • Table 48. Global Aesthetic Injectables Price Forecast by Application (2024-2029) & (US$/Unit)
  • Table 49. US & Canada Aesthetic Injectables Sales by Type (2018-2023) & (K Units)
  • Table 50. US & Canada Aesthetic Injectables Sales by Type (2024-2029) & (K Units)
  • Table 51. US & Canada Aesthetic Injectables Revenue by Type (2018-2023) & (US$ Million)
  • Table 52. US & Canada Aesthetic Injectables Revenue by Type (2024-2029) & (US$ Million)
  • Table 53. US & Canada Aesthetic Injectables Sales by Application (2018-2023) & (K Units)
  • Table 54. US & Canada Aesthetic Injectables Sales by Application (2024-2029) & (K Units)
  • Table 55. US & Canada Aesthetic Injectables Revenue by Application (2018-2023) & (US$ Million)
  • Table 56. US & Canada Aesthetic Injectables Revenue by Application (2024-2029) & (US$ Million)
  • Table 57. US & Canada Aesthetic Injectables Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 58. US & Canada Aesthetic Injectables Revenue by Country (2018-2023) & (US$ Million)
  • Table 59. US & Canada Aesthetic Injectables Revenue by Country (2024-2029) & (US$ Million)
  • Table 60. US & Canada Aesthetic Injectables Sales by Country (2018-2023) & (K Units)
  • Table 61. US & Canada Aesthetic Injectables Sales by Country (2024-2029) & (K Units)
  • Table 62. Europe Aesthetic Injectables Sales by Type (2018-2023) & (K Units)
  • Table 63. Europe Aesthetic Injectables Sales by Type (2024-2029) & (K Units)
  • Table 64. Europe Aesthetic Injectables Revenue by Type (2018-2023) & (US$ Million)
  • Table 65. Europe Aesthetic Injectables Revenue by Type (2024-2029) & (US$ Million)
  • Table 66. Europe Aesthetic Injectables Sales by Application (2018-2023) & (K Units)
  • Table 67. Europe Aesthetic Injectables Sales by Application (2024-2029) & (K Units)
  • Table 68. Europe Aesthetic Injectables Revenue by Application (2018-2023) & (US$ Million)
  • Table 69. Europe Aesthetic Injectables Revenue by Application (2024-2029) & (US$ Million)
  • Table 70. Europe Aesthetic Injectables Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 71. Europe Aesthetic Injectables Revenue by Country (2018-2023) & (US$ Million)
  • Table 72. Europe Aesthetic Injectables Revenue by Country (2024-2029) & (US$ Million)
  • Table 73. Europe Aesthetic Injectables Sales by Country (2018-2023) & (K Units)
  • Table 74. Europe Aesthetic Injectables Sales by Country (2024-2029) & (K Units)
  • Table 75. China Aesthetic Injectables Sales by Type (2018-2023) & (K Units)
  • Table 76. China Aesthetic Injectables Sales by Type (2024-2029) & (K Units)
  • Table 77. China Aesthetic Injectables Revenue by Type (2018-2023) & (US$ Million)
  • Table 78. China Aesthetic Injectables Revenue by Type (2024-2029) & (US$ Million)
  • Table 79. China Aesthetic Injectables Sales by Application (2018-2023) & (K Units)
  • Table 80. China Aesthetic Injectables Sales by Application (2024-2029) & (K Units)
  • Table 81. China Aesthetic Injectables Revenue by Application (2018-2023) & (US$ Million)
  • Table 82. China Aesthetic Injectables Revenue by Application (2024-2029) & (US$ Million)
  • Table 83. Asia Aesthetic Injectables Sales by Type (2018-2023) & (K Units)
  • Table 84. Asia Aesthetic Injectables Sales by Type (2024-2029) & (K Units)
  • Table 85. Asia Aesthetic Injectables Revenue by Type (2018-2023) & (US$ Million)
  • Table 86. Asia Aesthetic Injectables Revenue by Type (2024-2029) & (US$ Million)
  • Table 87. Asia Aesthetic Injectables Sales by Application (2018-2023) & (K Units)
  • Table 88. Asia Aesthetic Injectables Sales by Application (2024-2029) & (K Units)
  • Table 89. Asia Aesthetic Injectables Revenue by Application (2018-2023) & (US$ Million)
  • Table 90. Asia Aesthetic Injectables Revenue by Application (2024-2029) & (US$ Million)
  • Table 91. Asia Aesthetic Injectables Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 92. Asia Aesthetic Injectables Revenue by Region (2018-2023) & (US$ Million)
  • Table 93. Asia Aesthetic Injectables Revenue by Region (2024-2029) & (US$ Million)
  • Table 94. Asia Aesthetic Injectables Sales by Region (2018-2023) & (K Units)
  • Table 95. Asia Aesthetic Injectables Sales by Region (2024-2029) & (K Units)
  • Table 96. Middle East, Africa and Latin America Aesthetic Injectables Sales by Type (2018-2023) & (K Units)
  • Table 97. Middle East, Africa and Latin America Aesthetic Injectables Sales by Type (2024-2029) & (K Units)
  • Table 98. Middle East, Africa and Latin America Aesthetic Injectables Revenue by Type (2018-2023) & (US$ Million)
  • Table 99. Middle East, Africa and Latin America Aesthetic Injectables Revenue by Type (2024-2029) & (US$ Million)
  • Table 100. Middle East, Africa and Latin America Aesthetic Injectables Sales by Application (2018-2023) & (K Units)
  • Table 101. Middle East, Africa and Latin America Aesthetic Injectables Sales by Application (2024-2029) & (K Units)
  • Table 102. Middle East, Africa and Latin America Aesthetic Injectables Revenue by Application (2018-2023) & (US$ Million)
  • Table 103. Middle East, Africa and Latin America Aesthetic Injectables Revenue by Application (2024-2029) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America Aesthetic Injectables Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 105. Middle East, Africa and Latin America Aesthetic Injectables Revenue by Country (2018-2023) & (US$ Million)
  • Table 106. Middle East, Africa and Latin America Aesthetic Injectables Revenue by Country (2024-2029) & (US$ Million)
  • Table 107. Middle East, Africa and Latin America Aesthetic Injectables Sales by Country (2018-2023) & (K Units)
  • Table 108. Middle East, Africa and Latin America Aesthetic Injectables Sales by Country (2024-2029) & (K Units)
  • Table 109. Allergan Plc Company Information
  • Table 110. Allergan Plc Description and Major Businesses
  • Table 111. Allergan Plc Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 112. Allergan Plc Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 113. Allergan Plc Recent Developments
  • Table 114. Galderma SA Company Information
  • Table 115. Galderma SA Description and Major Businesses
  • Table 116. Galderma SA Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 117. Galderma SA Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 118. Galderma SA Recent Developments
  • Table 119. Merz Pharma GmbH & Co KgaA Company Information
  • Table 120. Merz Pharma GmbH & Co KgaA Description and Major Businesses
  • Table 121. Merz Pharma GmbH & Co KgaA Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 122. Merz Pharma GmbH & Co KgaA Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 123. Merz Pharma GmbH & Co KgaA Recent Developments
  • Table 124. Sinclair Pharma Plc Company Information
  • Table 125. Sinclair Pharma Plc Description and Major Businesses
  • Table 126. Sinclair Pharma Plc Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 127. Sinclair Pharma Plc Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 128. Sinclair Pharma Plc Recent Developments
  • Table 129. Teoxane SA Company Information
  • Table 130. Teoxane SA Description and Major Businesses
  • Table 131. Teoxane SA Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 132. Teoxane SA Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 133. Teoxane SA Recent Developments
  • Table 134. Bohus BioTech AB Company Information
  • Table 135. Bohus BioTech AB Description and Major Businesses
  • Table 136. Bohus BioTech AB Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 137. Bohus BioTech AB Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 138. Bohus BioTech AB Recent Developments
  • Table 139. AbbVie Inc Company Information
  • Table 140. AbbVie Inc Description and Major Businesses
  • Table 141. AbbVie Inc Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 142. AbbVie Inc Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 143. AbbVie Inc Recent Developments
  • Table 144. Huadong Medicine Co., Ltd Company Information
  • Table 145. Huadong Medicine Co., Ltd Description and Major Businesses
  • Table 146. Huadong Medicine Co., Ltd Aesthetic Injectables Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 147. Huadong Medicine Co., Ltd Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 148. Huadong Medicine Co., Ltd Recent Developments
  • Table 149. Key Raw Materials Lists
  • Table 150. Raw Materials Key Suppliers Lists
  • Table 151. Aesthetic Injectables Distributors List
  • Table 152. Aesthetic Injectables Customers List
  • Table 153. Aesthetic Injectables Market Trends
  • Table 154. Aesthetic Injectables Market Drivers
  • Table 155. Aesthetic Injectables Market Challenges
  • Table 156. Aesthetic Injectables Market Restraints
  • Table 157. Research Programs/Design for This Report
  • Table 158. Key Data Information from Secondary Sources
  • Table 159. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Aesthetic Injectables Product Picture
  • Figure 2. Global Aesthetic Injectables Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Aesthetic Injectables Market Share by Type in 2022 & 2029
  • Figure 4. Sunken Cheeks or Temples Product Picture
  • Figure 5. Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines) Product Picture
  • Figure 6. Plumping Up Lips Product Picture
  • Figure 7. Enhancing Facial Contour Product Picture
  • Figure 8. Global Aesthetic Injectables Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 9. Global Aesthetic Injectables Market Share by Application in 2022 & 2029
  • Figure 10. Hospital
  • Figure 11. Beauty Clinic
  • Figure 12. Aesthetic Injectables Report Years Considered
  • Figure 13. Global Aesthetic Injectables Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 14. Global Aesthetic Injectables Revenue 2018-2029 (US$ Million)
  • Figure 15. Global Aesthetic Injectables Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 16. Global Aesthetic Injectables Revenue Market Share by Region (2018-2029)
  • Figure 17. Global Aesthetic Injectables Sales 2018-2029 ((K Units)
  • Figure 18. Global Aesthetic Injectables Sales Market Share by Region (2018-2029)
  • Figure 19. US & Canada Aesthetic Injectables Sales YoY (2018-2029) & (K Units)
  • Figure 20. US & Canada Aesthetic Injectables Revenue YoY (2018-2029) & (US$ Million)
  • Figure 21. Europe Aesthetic Injectables Sales YoY (2018-2029) & (K Units)
  • Figure 22. Europe Aesthetic Injectables Revenue YoY (2018-2029) & (US$ Million)
  • Figure 23. China Aesthetic Injectables Sales YoY (2018-2029) & (K Units)
  • Figure 24. China Aesthetic Injectables Revenue YoY (2018-2029) & (US$ Million)
  • Figure 25. Asia (excluding China) Aesthetic Injectables Sales YoY (2018-2029) & (K Units)
  • Figure 26. Asia (excluding China) Aesthetic Injectables Revenue YoY (2018-2029) & (US$ Million)
  • Figure 27. Middle East, Africa and Latin America Aesthetic Injectables Sales YoY (2018-2029) & (K Units)
  • Figure 28. Middle East, Africa and Latin America Aesthetic Injectables Revenue YoY (2018-2029) & (US$ Million)
  • Figure 29. The Aesthetic Injectables Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 30. The Top 5 and 10 Largest Manufacturers of Aesthetic Injectables in the World: Market Share by Aesthetic Injectables Revenue in 2022
  • Figure 31. Global Aesthetic Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 32. Global Aesthetic Injectables Sales Market Share by Type (2018-2029)
  • Figure 33. Global Aesthetic Injectables Revenue Market Share by Type (2018-2029)
  • Figure 34. Global Aesthetic Injectables Sales Market Share by Application (2018-2029)
  • Figure 35. Global Aesthetic Injectables Revenue Market Share by Application (2018-2029)
  • Figure 36. US & Canada Aesthetic Injectables Sales Market Share by Type (2018-2029)
  • Figure 37. US & Canada Aesthetic Injectables Revenue Market Share by Type (2018-2029)
  • Figure 38. US & Canada Aesthetic Injectables Sales Market Share by Application (2018-2029)
  • Figure 39. US & Canada Aesthetic Injectables Revenue Market Share by Application (2018-2029)
  • Figure 40. US & Canada Aesthetic Injectables Revenue Share by Country (2018-2029)
  • Figure 41. US & Canada Aesthetic Injectables Sales Share by Country (2018-2029)
  • Figure 42. U.S. Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 43. Canada Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 44. Europe Aesthetic Injectables Sales Market Share by Type (2018-2029)
  • Figure 45. Europe Aesthetic Injectables Revenue Market Share by Type (2018-2029)
  • Figure 46. Europe Aesthetic Injectables Sales Market Share by Application (2018-2029)
  • Figure 47. Europe Aesthetic Injectables Revenue Market Share by Application (2018-2029)
  • Figure 48. Europe Aesthetic Injectables Revenue Share by Country (2018-2029)
  • Figure 49. Europe Aesthetic Injectables Sales Share by Country (2018-2029)
  • Figure 50. Germany Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 51. France Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 52. U.K. Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 53. Italy Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 54. Russia Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 55. China Aesthetic Injectables Sales Market Share by Type (2018-2029)
  • Figure 56. China Aesthetic Injectables Revenue Market Share by Type (2018-2029)
  • Figure 57. China Aesthetic Injectables Sales Market Share by Application (2018-2029)
  • Figure 58. China Aesthetic Injectables Revenue Market Share by Application (2018-2029)
  • Figure 59. Asia Aesthetic Injectables Sales Market Share by Type (2018-2029)
  • Figure 60. Asia Aesthetic Injectables Revenue Market Share by Type (2018-2029)
  • Figure 61. Asia Aesthetic Injectables Sales Market Share by Application (2018-2029)
  • Figure 62. Asia Aesthetic Injectables Revenue Market Share by Application (2018-2029)
  • Figure 63. Asia Aesthetic Injectables Revenue Share by Region (2018-2029)
  • Figure 64. Asia Aesthetic Injectables Sales Share by Region (2018-2029)
  • Figure 65. Japan Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 66. South Korea Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 67. China Taiwan Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 68. Southeast Asia Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 69. India Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 70. Middle East, Africa and Latin America Aesthetic Injectables Sales Market Share by Type (2018-2029)
  • Figure 71. Middle East, Africa and Latin America Aesthetic Injectables Revenue Market Share by Type (2018-2029)
  • Figure 72. Middle East, Africa and Latin America Aesthetic Injectables Sales Market Share by Application (2018-2029)
  • Figure 73. Middle East, Africa and Latin America Aesthetic Injectables Revenue Market Share by Application (2018-2029)
  • Figure 74. Middle East, Africa and Latin America Aesthetic Injectables Revenue Share by Country (2018-2029)
  • Figure 75. Middle East, Africa and Latin America Aesthetic Injectables Sales Share by Country (2018-2029)
  • Figure 76. Brazil Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 77. Mexico Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 78. Turkey Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 79. Israel Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 80. GCC Countries Aesthetic Injectables Revenue (2018-2029) & (US$ Million)
  • Figure 81. Aesthetic Injectables Value Chain
  • Figure 82. Aesthetic Injectables Production Process
  • Figure 83. Channels of Distribution
  • Figure 84. Distributors Profiles
  • Figure 85. Bottom-up and Top-down Approaches for This Report
  • Figure 86. Data Triangulation
  • Figure 87. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!